Pharmacy

News

Ibrutinib gets EU approval for CLL, MCL

Credit: Steven Harbour The European Commission has granted marketing approval for the Bruton’s tyrosine kinase inhibitor ibrutinib (Imbruvica) in...

News

FDA approves drug for nausea, vomiting

Palonosetron prevents nausea and vomiting in the acute phase—within the first 24 hours of chemotherapy initiation. Netupitant prevents nausea and...

News

FDA approves drug for untreated MCL

The US Food and Drug Administration (FDA) has approved bortezomib (Velcade) for use in previously untreated patients with mantle cell lymphoma (...

Pages